Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
Ashby J, Tinwell H, Callander RD, Kimber I, Clay P, Galloway SM, Hill RB, Greenwood SK, Gaulden ME, Ferguson MJ, Vogel E, Nivard M, Parry JM, Williamson J.
Ashby J, et al. Among authors: hill rb.
Mutat Res. 1997 Dec 12;396(1-2):45-64. doi: 10.1016/s0027-5107(97)00174-7.
Mutat Res. 1997.
PMID: 9434859